Literature DB >> 17569906

FDA places "black box" warning on antidiabetes drugs.

Janice Hopkins Tanne.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17569906      PMCID： PMC1892463          DOI： 10.1136/bmj.39244.394456.DB

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011.

Authors:  Sei J Lee; Irena Stijacic-Cenzer; Caroline Barnhart; Keelan McClymont; Michael A Steinman
Journal:  J Am Med Dir Assoc       Date:  2015-08-10       Impact factor: 4.669

2.  Drug-related risks.

Authors:  Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11       Impact factor: 2.953

3.  National Trends in Treatment Initiation for Nursing Home Residents With Diabetes Mellitus, 2008 to 2010.

Authors:  Andrew R Zullo; David D Dore; Lori Daiello; Rosa R Baier; Roee Gutman; David R Gifford; Robert J Smith
Journal:  J Am Med Dir Assoc       Date:  2016-03-24       Impact factor: 4.669

4.  Unbalanced reporting of benefits and harms in abstracts on rofecoxib.

Authors:  Anders W Jørgensen; Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  Eur J Clin Pharmacol       Date:  2010-02-17       Impact factor: 2.953

5.  Curcumin-mediated effects on anti-diabetic drug-induced cardiotoxicity.

Authors:  Aditi Jain; Vibha Rani
Journal:  3 Biotech       Date:  2018-09-07       Impact factor: 2.406

6.  The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration Modeling.

Authors:  Sreenivasa C Ramaiahgari; Scott S Auerbach; Trey O Saddler; Julie R Rice; Paul E Dunlap; Nisha S Sipes; Michael J DeVito; Ruchir R Shah; Pierre R Bushel; Bruce A Merrick; Richard S Paules; Stephen S Ferguson
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

7.  The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.

Authors:  Alexandra K Lee; Mark Woodward; Dan Wang; Toshiaki Ohkuma; Bethany Warren; A Richey Sharrett; Bryan Williams; Michel Marre; Pavel Hamet; Stephen Harrap; John W Mcevoy; John Chalmers; Elizabeth Selvin
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

8.  Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment.

Authors:  Koichi Node; Teruo Inoue; Valentin Boyko; Ilan Goldberg; Enrique Z Fisman; Yehuda Adler; Ehud Schwammenthal; Zipora Matas; Solomon Behar; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2009-01-28       Impact factor: 9.951

9.  Should We Use PPAR Agonists to Reduce Cardiovascular Risk?

Authors:  Jennifer G Robinson
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.